Browse > Article
http://dx.doi.org/10.5653/cerm.2012.39.1.15

Tributyltin increases the expression of apoptosis- and adipogenesis-related genes in rat ovaries  

Lee, Hyo-Jin (Department of Bioenvironmental Technology, College of Natural Sciences, Seoul Women's University)
Lim, So-Jeong (Department of Bioenvironmental Technology, College of Natural Sciences, Seoul Women's University)
Yun, Su-Jin (Department of Bioenvironmental Technology, College of Natural Sciences, Seoul Women's University)
Yoon, A-Young (Department of Bioenvironmental Technology, College of Natural Sciences, Seoul Women's University)
Park, Ga-Young (Department of Bioenvironmental Technology, College of Natural Sciences, Seoul Women's University)
Yang, Hyun-Won (Department of Bioenvironmental Technology, College of Natural Sciences, Seoul Women's University)
Publication Information
Clinical and Experimental Reproductive Medicine / v.39, no.1, 2012 , pp. 15-21 More about this Journal
Abstract
Objective: Tributyltin (TBT), an endocrine disrupting chemical, has been reported to decrease ovarian function by causing apoptosis in the ovary, but the mechanism is not fully understood. Therefore, we examined whether TBT increases the expression of adipogenesis-related genes in the ovary and the increased expression of these genes is associated with apoptosis induction. Methods: Three-week-old Sprague-Dawley rats were orally administered TBT (1 or 10 mg/kg body weight) or sesame oil as a control for 7 days. The ovaries were obtained and weighed on day 8, and then they were fixed for terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) or frozen for RNA extraction. Using the total RNA of the ovaries, adipogenesis- and apoptosis-related genes were analyzed by real-time polymerase chain reaction (PCR). Results: The ovarian weight was significantly decreased in rats administered 10 mg/kg TBT compared to that in control rats. As determined by the TUNEL assay, the number of apoptotic follicles in ovary was significantly increased in rats administered 10 mg/kg TBT. The real-time PCR results showed that the expression of adipogenesis-related genes such as $PPAR{\gamma}$, ${\alpha}P2$, CD36, and PEPCK was increased after TBT administration. In addition, apoptosis-related genes such as $TNF{\alpha}$ and TNFR1 were expressed more in the TBT-administered rats compared with the control rats. Conclusion: The present study demonstrates that TBT induces the expression of adipogenesis- and apoptosis-related genes in the ovary leading to apoptosis in the ovarian follicles. These results suggest that the increased expression of adipogenesis-related genes in the ovary by TBT exposure might induce apoptosis resulting in a loss of ovarian function.
Keywords
Adipogenesis; Apoptosis; Ovarian follicle; Ovary; Tributyltin; Sprague-Dawley rats;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Lee CW, Choi KH, Jeong SW, Kim HL, Seo YR. An overview and future perspective on endocrine disruptors. J Korean Endocr Soc 2009;24:7-14.
2 Appel KE. Organotin compounds: toxicokinetic aspects. Drug Metab Rev 2004;36:763-86.
3 Blaber SJ. The occurrence of a penis-like outgrowth behind the right tentacle in spent females of Nucella lapillus. J Molluscan Stud 1970;39:231-3.
4 Ogata R, Omura M, Shimasaki Y, Kubo K, Oshima Y, Aou S, et al. Two-generation reproductive toxicity study of tributyltin chloride in female rats. J Toxicol Environ Health A 2001;63:127-44.
5 Boyer IJ. Toxicity of dibutyltin, tributyltin and other organotin compounds to humans and to experimental animals. Toxicology 1989;55:253-98.
6 Heidrich DD, Steckelbroeck S, Klingmuller D. Inhibition of human cytochrome P450 aromatase activity by butyltins. Steroids 2001; 66:763-9.
7 Powers MF, Beavis AD. Triorganotins inhibit the mitochondrial inner membrane anion channel. J Biol Chem 1991;266:17250-6.
8 Philbert MA, Billingsley ML, Reuhl KR. Mechanisms of injury in the central nervous system. Toxicol Pathol 2000;28:43-53.
9 Mu YM, Yanase T, Nishi Y, Takayanagi R, Goto K, Nawata H. Combined treatment with specific ligands for PPARgamma:RXR nuclear receptor system markedly inhibits the expression of cytochrome P450arom in human granulosa cancer cells. Mol Cell Endocrinol 2001;181:239-48.
10 Saitoh M, Yanase T, Morinaga H, Tanabe M, Mu YM, Nishi Y, et al. Tributyltin or triphenyltin inhibits aromatase activity in the human granulosa-like tumor cell line KGN. Biochem Biophys Res Commun 2001;289:198-204.
11 Michalik L, Auwerx J, Berger JP, Chatterjee VK, Glass CK, Gonzalez FJ, et al. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol Rev 2006;58:726-41.
12 Berger J, Moller DE. The mechanisms of action of PPARs. Annu Rev Med 2002;53:409-35.
13 le Maire A, Grimaldi M, Roecklin D, Dagnino S, Vivat-Hannah V, Balaguer P, et al. Activation of RXR-PPAR heterodimers by organotin environmental endocrine disruptors. EMBO Rep 2009;10:367-73.
14 Minge CE, Bennett BD, Norman RJ, Robker RL. Peroxisome proliferator- activated receptor-gamma agonist rosiglitazone reverses the adverse effects of diet-induced obesity on oocyte quality. Endocrinology 2008;149:2646-56.
15 Kirchner S, Kieu T, Chow C, Casey S, Blumberg B. Prenatal exposure to the environmental obesogen tributyltin predisposes multipotent stem cells to become adipocytes. Mol Endocrinol 2010;24:526-39.
16 Komar CM. Peroxisome proliferator-activated receptors (PPARs) and ovarian function: implications for regulating steroidogenesis, differentiation, and tissue remodeling. Reprod Biol Endocrinol 2005;3:41.
17 Kim J, Sato M, Li Q, Lydon JP, Demayo FJ, Bagchi IC, et al. Peroxisome proliferator-activated receptor gamma is a target of progesterone regulation in the preovulatory follicles and controls ovulation in mice. Mol Cell Biol 2008;28:1770-82.
18 Komar CM, Curry TE Jr. Inverse relationship between the expression of messenger ribonucleic acid for peroxisome proliferatoractivated receptor gamma and P450 side chain cleavage in the rat ovary. Biol Reprod 2003;69:549-55.
19 Yamasaki K, Sawaki M, Takatsuki M. Immature rat uterotrophic assay of bisphenol A. Environ Health Perspect 2000;108:1147-50.
20 Jones JR, Barrick C, Kim KA, Lindner J, Blondeau B, Fujimoto Y, et al. Deletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance. Proc Natl Acad Sci U S A 2005;102:6207-12.
21 Chawla A, Schwarz EJ, Dimaculangan DD, Lazar MA. Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology 1994;135:798-800.
22 McVey MJ, Cooke GM. Inhibition of rat testis microsomal 3betahydroxysteroid dehydrogenase activity by tributyltin. J Steroid Biochem Mol Biol 2003;86:99-105.
23 Nakanishi T. Organotin-induced toxicity and nuclear receptor signaling. Biomed Res Trace Elem 2006;17:373-81.
24 Cangialosi MV, Puccia E, Mazzola A, Mansueto V, Arukwe A. Screening of ovarian steroidogenic pathway in Ciona intestinalis and its modulation after tributyltin exposure. Toxicol Appl Pharmacol 2010;245:124-33.
25 Nakanishi T. Endocrine disruption induced by organotin compounds; organotins function as a powerful agonist for nuclear receptors rather than an aromatase inhibitor. J Toxicol Sci 2008;33:269-76.
26 Gregoire FM, Smas CM, Sul HS. Understanding adipocyte differentiation. Physiol Rev 1998;78:783-809.
27 Carfi' M, Croera C, Ferrario D, Campi V, Bowe G, Pieters R, et al. TBTC induces adipocyte differentiation in human bone marrow long term culture. Toxicology 2008;249:11-8.
28 Shao D, Lazar MA. Peroxisome proliferator activated receptor gamma, CCAAT/enhancer-binding protein alpha, and cell cycle status regulate the commitment to adipocyte differentiation. J Biol Chem 1997;272:21473-8.
29 Febbraio M, Hajjar DP, Silverstein RL. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest 2001;108:785-91.
30 Ibrahimi A, Sfeir Z, Magharaie H, Amri EZ, Grimaldi P, Abumrad NA. Expression of the CD36 homolog (FAT) in fibroblast cells: effects on fatty acid transport. Proc Natl Acad Sci U S A 1996;93:2646-51.
31 Ashkenazi A, Dixit VM. Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 1999;11:255-60.
32 Chakravarty K, Cassuto H, Reshef L, Hanson RW. Factors that control the tissue-specific transcription of the gene for phosphoenolpyruvate carboxykinase-C. Crit Rev Biochem Mol Biol 2005;40:129-54.
33 Kaipia A, Chun SY, Eisenhauer K, Hsueh AJ. Tumor necrosis factor-alpha and its second messenger, ceramide, stimulate apoptosis in cultured ovarian follicles. Endocrinology 1996;137:4864-70.
34 Sharov AA, Falco G, Piao Y, Poosala S, Becker KG, Zonderman AB, et al. Effects of aging and calorie restriction on the global gene expression profiles of mouse testis and ovary. BMC Biol 2008;6:24.
35 Schneider P, Tschopp J. Apoptosis induced by death receptors. Pharm Acta Helv 2000;74:281-6.
36 Korzekwa A, Murakami S, Woclawek-Potocka I, Bah MM, Okuda K, Skarzynski DJ. The influence of tumor necrosis factor alpha (TNF) on the secretory function of bovine corpus luteum: TNF and its receptors expression during the estrous cycle. Reprod Biol 2008; 8:245-62.